Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
POAI | US
-0.08
-11.63%
Healthcare
Medical Instruments & Supplies
30/06/2024
04/10/2024
0.64
0.68
0.68
0.64
Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company through the integration of scientific rigor and machine learning has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples. It operates through four segments: Helomics zPREDICTA Soluble and Skyline. The Helomics segment provides services that include the application of AI collaboration projects and clinical testing. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using a self-contained automated system that conducts self-interaction chromatography screens using additives and excipients included in protein formulations resulting in soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System a wall-mounted fully automated system which virtually eliminates exposure to blood irrigation fluid and other infectious fluids found in the healthcare environment. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Eagan Minnesota.
View LessValue Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
71.5%1 month
60.6%3 months
175.0%6 months
157.8%-
-
1.23
0.66
0.25
-0.51
1.38
-
-13.44M
4.29M
4.29M
-
-1.14K
-
-43.10
-149.36
0.52
0.97
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.24
Range1M
0.34
Range3M
2.35
Rel. volume
1.32
Price X volume
70.88K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Sharps Technology Inc. | STSS | Medical Instruments & Supplies | 0.1524 | 4.36M | -0.78% | n/a | 0.00% |
Acutus Medical Inc | AFIB | Medical Devices | 0.122 | 3.65M | 45.24% | n/a | -745.93% |
Common Stock | VERO | Medical Devices | 0.4488 | 3.26M | -12.00% | n/a | 1351.51% |
Talis Biomedical Corporation Common Stock | TLIS | Medical Devices | 1.78 | 3.24M | -6.32% | n/a | 38.66% |
INVO Bioscience Inc | INVO | Medical Devices | 0.7 | 2.73M | 3.55% | 1.03 | 394.32% |
ThermoGenesis Holdings Inc | THMO | Medical Devices | 0.16 | 2.54M | 1.20% | n/a | 776.10% |
NUWE | NUWE | Medical Devices | 1.32 | 2.46M | -10.81% | n/a | -9.57% |
Sintx Technologies Inc | SINT | Medical Devices | 3.23 | 2.41M | 0.94% | n/a | 47.07% |
Tenon Medical Inc | TNON | Medical Devices | 4.24 | 2.40M | -0.93% | n/a | 67.43% |
Bluejay Diagnostics Inc. Common Stock | BJDX | Medical Devices | 0.1342 | 2.22M | 9.19% | n/a | 5.12% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
No data |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.51 | 7.69 | Cheaper |
Ent. to Revenue | 1.38 | 64.13 | Cheaper |
PE Ratio | - | 50.95 | - |
Price to Book | 1.23 | 6.11 | Cheaper |
Dividend Yield | - | 1.34 | - |
Std. Deviation (3M) | 174.99 | 55.82 | Riskier |
Debt to Equity | 0.66 | 0.86 | Cheaper |
Debt to Assets | 0.25 | 0.26 | Par |
Market Cap | 4.29M | 9.95B | Emerging |